[AI]■ STORY TIMELINE
NOVO NORDISK PARTNERS WITH OPENAI FOR DRUG DEVELOPMENT
Novo Nordisk has integrated OpenAI's artificial intelligence across its operations to accelerate the development of new obesity medications. The partnership leverages AI to streamline research and development processes.
Bloomberg Tech+0m
Novo Nordisk A/S will integrate OpenAI’s artificial intelligence across the company to accelerate drug development.